期刊文献+

血清PSA、f-PSA/t-PSA在前列腺癌诊断中的意义 被引量:3

DIAGNOSTIC SIGNIFICANCE OF SERUM PSA AND F-PSA/T-PSA FOR PROSTATIC CANCER
下载PDF
导出
摘要 目的探讨血清PSA、f-PSA/t-PSA在前列腺癌(PCa)诊断中的意义。方法回顾性分析51例前列腺癌与44例前列腺良性增生(BPH)患者血清PSA、f-PSA/t-PSA值在前列腺癌鉴别诊断中的意义。结果 PCa与BPH两组患者间PSA、f-PSA/t-PSA有显著差异(p<0.01)。当PSA介于4.0~10.0μg/L之间,两组患者间PSA水平无显著性差异(p>0.05),而f-PSA/t-PSA有显著性差异(p<0.01)。且PSA介于4.0~10.0μg/L之间,f-PSA/t-PSA分别为0.10、0.16、0.25时,对PCa诊断的灵敏度为37.3%、77.1%、95.4%;特异性为96.9%、82.8%、53.2%。结论 PCa患者PSA显著升高,f-PSA/t-PSA则显著降低。而PSA介于4.0~10.0μg/L之间,PSA无诊断意义,选择f-PSA/t-PSA为0.16作为临界值,对PCa的诊断有较高的灵敏度和特异性。 Objective To investigate the diagnostic significance of serum PSA and f-PSA/t-PSA for prostatic cancer(Pca).Methods Serum PSA and f-PSA/t-PSA of 51 patients with prostatic cancer and 44 patients with benign prostate hyperplasia(BPH) were analyzed retrospectively.Results The differences o4f serum PSA and f-PSA/t-PSA between two groups were significant(p0.01).When serum PSA was between 4.0~10.0 μg/L,the difference of serum PSA between two groups was not significant(p0.05),but in serum f-PSA/t-PSA,the difference was significant(p0.01).And When serum PSA was between 4.0~10.0 μg/L,serum f-PSA/t-PSA was 0.10,0.16,0.25 respectively,the sensitivity for diagnosing Pca were 37.3%,77.1%,95.4%,respectively,the specificity of them were 96.9%,82.8%,53.2%,respectively.Conclusion The level of serum PSA in patients with Pca significantly increased,Serum f-PSA/t-PSA significantly decreased.If serum PSA was between 4.0~10.0 μg/L,It was no valuable for diagnosing prostatic cancer.It has high sensitivity and specificity for diagnosing prostatic cancer(Pca) to select 0.16 as critical value of serum f-PSA/t-PSA.
出处 《现代医院》 2010年第12期9-10,共2页 Modern Hospitals
关键词 前列腺癌 前列腺良性增生 前列腺特异性抗原 游离PSA比率 Prostatic cancer Benign prostate hyperplasia Prostate specific antigen Freeing proportion of prostate specific antigen
  • 相关文献

参考文献9

二级参考文献54

  • 1曾科,李洪勤,王可超,李政,潘校诚,肖泽钊.经尿道等离子双极电切术治疗良性前列腺增生85例[J].实用医学杂志,2007,23(2):247-248. 被引量:1
  • 2Christensson A, Bjork T, Nilsson O, et al. Serum prostate specific antigen complexed to alpha 1-antichymotrypsin as an indicator of prostate cancer. J Urol 1993:150 (1): 100-105.
  • 3Okihara K, Cheli CD, Partin AW, et al. Comparative analysis of complexed prostate specific antigen, free prostate specific antigen and their ratio in detecting prostate cancer. J Urol 2002:167 (5): 2017-2023.
  • 4Ozdal OL, Aprikian, AG, Beegin LR, et al. Comparative evaluation of various prostate specific antigen ratios for the early detection of prostate cancer. BJU Int 2004; 93 (7): 970-974.
  • 5Carter HB, Pearson JD, Metter EJ, et al. Longitudinal evaluation of prostate-specific antigen levels in men with and without prostate disease. JAMA 1992; 267(16): 2215-2220.
  • 6McCormack RT, Rittenhouse HG, Finlay JA, et al. Molecular forms of prostate-specific antigen and the human kallikrein gene family: a new era. Urology 1995:45 (5): 729-744.
  • 7Catalona WJ, Southwick PC, Slawin KM, et al. Comparison of percent free PSA, PSA density, and age-specific PSA cuoffs for prostate cancer detection and staging. Urology 2000:56 (2): 255-260.
  • 8Miller MC, O'Dowd GJ, Partin AW, et al. Contemporary use of complexed PSA and calculated percent free PSA for early detection of prostate cancer: impact of changing disease demographics. Urology 2001:57 (6): 1105-1111.
  • 9Tanguary S, Begin LR, Elhilali MM, et al. Comparative evaluation of total PSA, free/total PSA, and complexed PSA in prostate cancer detection. Urology 2002:59 (2): 261-265.
  • 10Jung K, Elgeti U, Lein M, et al. Ratio of free or complexed prostate-specific antigen (PSA) to total PSA: which ratio improves differentiation between benign prostatic hyperplasia and prostate cancer? Clin Chem 2000:46 (1): 55-62.

共引文献44

同被引文献19

引证文献3

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部